ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $420,000 | -9.3% | 17,225 | -37.6% | 0.01% | 0.0% |
Q2 2018 | $463,000 | +127.0% | 27,600 | +120.8% | 0.01% | +100.0% |
Q1 2018 | $204,000 | -69.8% | 12,500 | -87.5% | 0.00% | -62.5% |
Q3 2016 | $675,000 | -5.2% | 100,000 | -50.0% | 0.01% | +100.0% |
Q2 2016 | $712,000 | +141.4% | 200,000 | +100.0% | 0.00% | 0.0% |
Q1 2016 | $295,000 | -30.3% | 100,000 | -0.2% | 0.00% | -33.3% |
Q4 2015 | $423,000 | +2.7% | 100,250 | +11.1% | 0.01% | 0.0% |
Q3 2015 | $412,000 | -24.1% | 90,250 | +19.9% | 0.01% | 0.0% |
Q2 2015 | $543,000 | +54200.0% | 75,250 | +30000.0% | 0.01% | – |
Q2 2014 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
Q1 2014 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
Q4 2013 | $1,000 | – | 250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |